NYSE:HYH - Halyard Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $57.25 +0.04 (+0.07 %) (As of 09/21/2018 04:36 AM ET)Previous Close$57.21Today's Range$56.93 - $57.9152-Week Range$38.22 - $61.52Volume886,271 shsAverage Volume438,537 shsMarket Capitalization$2.69 billionP/E Ratio24.36Dividend YieldN/ABeta1.67 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Halyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Receive HYH News and Ratings via Email Sign-up to receive the latest news and ratings for HYH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical SymbolNYSE:HYH CUSIPN/A Webwww.halyardhealth.com Phone678-425-9273 Debt Debt-to-Equity Ratio0.43 Current Ratio3.22 Quick Ratio2.96 Price-To-Earnings Trailing P/E Ratio24.36 Forward P/E Ratio32.71 P/E Growth3.68 Sales & Book Value Annual Sales$611.60 million Price / Sales4.40 Cash Flow$1.2427 per share Price / Cash46.07 Book Value$25.95 per share Price / Book2.21 Profitability EPS (Most Recent Fiscal Year)$2.35 Net Income$79.30 million Net Margins7.72% Return on Equity7.90% Return on Assets4.38% Miscellaneous Employees13,000 Outstanding Shares47,020,000Market Cap$2.69 billion Halyard Health (NYSE:HYH) Frequently Asked Questions What is Halyard Health's stock symbol? Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH." How were Halyard Health's earnings last quarter? Halyard Health (NYSE:HYH) released its quarterly earnings data on Wednesday, November, 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.13. The medical instruments supplier earned $401.40 million during the quarter, compared to analyst estimates of $394.54 million. Halyard Health had a return on equity of 7.90% and a net margin of 7.72%. The company's revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company posted $0.48 EPS. View Halyard Health's Earnings History. What price target have analysts set for HYH? 4 equities research analysts have issued 12 month price objectives for Halyard Health's shares. Their forecasts range from $50.00 to $67.00. On average, they expect Halyard Health's stock price to reach $59.25 in the next year. This suggests a possible upside of 3.5% from the stock's current price. View Analyst Price Targets for Halyard Health. What is the consensus analysts' recommendation for Halyard Health? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halyard Health in the last year. There are currently 1 sell rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Halyard Health. Who are some of Halyard Health's key competitors? Some companies that are related to Halyard Health include Steris (STE), Inogen (INGN), MSA Safety (MSA), Avanos Medical (AVNS), Wright Medical Group (WMGI), CONSORT Med PLC/S (CSRMY), Sientra (SIEN), Invacare (IVC), Establishment Labs (ESTA), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), Rewalk Robotics (RWLK), COLLPLANT HOLDI/S (CLGN) and NanoVibronix (NAOV). Who are Halyard Health's key executives? Halyard Health's management team includes the folowing people: Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)Mr. Joseph F. Woody, CEO & Director (Age 52)Mr. Renato Negro, VP, Controller & Chief Accounting Officer Has Halyard Health been receiving favorable news coverage? News coverage about HYH stock has been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Halyard Health earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave press coverage about the medical instruments supplier an impact score of 46.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for Halyard Health. Who are Halyard Health's major shareholders? Halyard Health's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.02%), Dimensional Fund Advisors LP (6.90%), Paradice Investment Management LLC (3.11%), Channing Capital Management LLC (2.38%), Victory Capital Management Inc. (2.26%) and Northern Trust Corp (2.06%). View Institutional Ownership Trends for Halyard Health. Which institutional investors are selling Halyard Health stock? HYH stock was sold by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Northern Trust Corp, Dimensional Fund Advisors LP, Paradice Investment Management LLC, Channing Capital Management LLC, Associated Banc Corp, Schwab Charles Investment Management Inc. and Spark Investment Management LLC. View Insider Buying and Selling for Halyard Health. Which institutional investors are buying Halyard Health stock? HYH stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Castleark Management LLC, BlackRock Inc., Renaissance Technologies LLC, Zacks Investment Management, Chartwell Investment Partners LLC, Select Equity Group L.P. and Trexquant Investment LP. View Insider Buying and Selling for Halyard Health. How do I buy shares of Halyard Health? Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Halyard Health's stock price today? One share of HYH stock can currently be purchased for approximately $57.25. How big of a company is Halyard Health? Halyard Health has a market capitalization of $2.69 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe. How can I contact Halyard Health? Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected] MarketBeat Community Rating for Halyard Health (NYSE HYH)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 215 (Vote Outperform)Underperform Votes: 225 (Vote Underperform)Total Votes: 440MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/21/2018 by MarketBeat.com StaffFeatured Article: Do Tariffs Work?